Orchid Pharma Approves Allotment of 4.45 Cr Shares for Amalgamation

Orchid Pharma Ltd's Board of Directors has approved the issuance and allotment of 4,45,86,052 fully paid-up equity shares of Rs. 10 each to eligible shareholders of Dhanuka Laboratories Limited. This allotment is pursuant to the scheme of Amalgamation, with the shares proposed to be listed on BSE and NSE. Following the allotment and cancellation of cross-holding, the company's paid-up share capital has increased to Rs. 59,88,52,000, comprising 5,98,85,200 equity shares. The record date for this allotment was July 23, 2026.